You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 9, September 1990 TABLE OF CONTENTS
  Archives
  •  Online Features
  STUDIES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

19-DEJ-1, a Monoclonal Antibody to the Hemidesmosome-Anchoring Filament Complex, Is the Only Reliable Immunohistochemical Probe for All Major Forms of Junctional Epidermolysis Bullosa

Jo-David Fine, MD

Arch Dermatol. 1990;126(9):1187-1190.


Abstract

• Recently, a monocional antibody, 19-DEJ-1, has been described with binding specificity for an epitope present within the mid-lamina lucida of the dermoepidermal junction directly underneath hemidesmosomes, suggesting recognition of a portion of the anchoring filaments. In an initial survey of specimens from patients with inherited epidermolysis bullosa (EB), it was noted that 9 of 9 specimens of Herlitz junctional EB and approximately 50% of specimens of recessive dystrophic EB lacked staining of the dermoepidermal junction with this antibody. To better define the sensitivity of binding by 19-DEJ-1 in junctional EB skin, 40 consecutive specimens representing the three major subtypes (Herlitz, 14; non-Herlitz, 15; and indeterminate, 11) were examined. No staining was noted along the dermoepidermal junction in any specimen, regardless of junctional EB subtype. Considering the recently discovered variability of binding by GB3 monoclonal antibody in some junctional EB subtypes, based on the present data it appears that the 19-DEJ-1 monoclonal antibody is the only immunohistochemical probe that can be used reliably for diagnosis of all major forms of junctional EB. Furthermore, these data suggest the possible utility of this particular antibody as a probe for identification, at the molecular level, of a basement membrane defect shared among all major forms of junctional EB.

(Arch Dermatol. 1990;126:1187-1190)



Author Affiliations

From the Department of Dermatology, University of Alabama School of Medicine, Birmingham.


Footnotes

Accepted for publication March 6, 1990.

Reprint requests to the Department of Dermatology, University of North Carolina at Chapel Hill, Room 137, North Carolina Memorial Hospital, Chapel Hill, NC 27514 (Dr Fine).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prenatal Diagnosis of Genetic Skin Disease Using Fetal Skin Biopsy Samples
Holbrook et al.
Arch Dermatol 1993;129:1437-1454.
ABSTRACT  

The Pyloric Atresia--Junctional Epidermolysis Bullosa Syndrome: Report of a Case and Review of the Literature
Lestringant et al.
Arch Dermatol 1992;128:1083-1086.
ABSTRACT  

Type VII Collagen and 19-DEJ-1 Antigen: Comparison of Expression in Inversa and Generalized Variants of Recessive Dystrophic Epidermolysis Bullosa
Fine et al.
Arch Dermatol 1990;126:1587-1593.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.